
The Centers for Medicare & Medicaid Services (CMS) announced on Friday that Medicare Advantage (MA) and Medicare Part D prescription drug program premiums, benefits and plan options are expected to remain largely stable in 2026.
Average premiums are projected to decline slightly, reinforcing CMS’s commitment to providing beneficiaries access to affordable, high-quality health care while protecting taxpayer dollars.